Guru Ownership Trend
Guru Analysis for Caribou Biosciences, Inc. (CRBU)
Caribou Biosciences, Inc. (CRBU), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.97 M.
Top institutional holders include Renaissance Technologies (RenTech) and Lee Ainslie.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $73,278.01 net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 7.1%. Conversely, Steven Cohen reduced exposure by 91.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Caribou Biosciences, Inc. (CRBU)
Major holders include Renaissance Technologies (RenTech) ($4.88 M), Lee Ainslie ($1.15 M), Robert Bruce ($440,000). According to the latest reported data, 4 tracked investment managers collectively hold approximately 3.69 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $73,278.01, with 1 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited CRBU. The total reported sell value was $395,442.48.
Yes, 0 managers opened new positions in CRBU, and 1 increased their existing holdings. The total reported buy value was $322,164.47.